跳至主要内容
临床试验/NCT02038530
NCT02038530
已完成
不适用

D-dimer Testing, Tailored to Clinical Pretest Probability, to Minimize Initial and Follow-up Ultrasound Imaging in Suspected Deep Vein Thrombosis: A Management Study

McMaster University10 个研究点 分布在 1 个国家目标入组 1,513 人2014年2月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Suspected Deep Vein Thrombosis
发起方
McMaster University
入组人数
1513
试验地点
10
主要终点
Confirmed symptomatic proximal Deep Vein Thrombosis
状态
已完成
最后更新
4年前

概览

简要总结

This is a cohort study that will assess a new diagnostic management strategy for suspected Deep Vein Thrombosis in outpatients.The new diagnostic strategy is designed to reduce the use of ultrasound testing on the day of presentation, and reduce repeat ultrasound testing a week after an initial normal test.

详细描述

This is a prospective, multicentre, cohort study that will assess a new diagnostic management strategy for suspected Deep Vein Thrombosis in outpatients. The new diagnostic strategy is designed to reduce the use of ultrasound testing on the day of presentation, and reduce repeat ultrasound testing a week after an initial normal test. Less ultrasound testing will be performed because: i) more patients will have deep vein thrombosis excluded by combinations of Clinical Pretest Probability and D-dimer results on the day of presentation; and, ii) in those who still need an ultrasound, a repeat ultrasound a week after a normal result will only be performed if the D-dimer result is markedly abnormal at initial presentation. The safety of this management strategy will be established by demonstrating a very low rate of proximal Deep Vein Thrombosis or Pulmonary Embolism during 90 days follow-up in patients who had anticoagulant therapy withheld in response to negative diagnostic testing. Diagnostic test utilization will be assessed. All clinical outcomes will be adjudicated by a central independent adjudication committee that will be blind to initial D-dimer measurements and patient management.

注册库
clinicaltrials.gov
开始日期
2014年2月
结束日期
2020年10月15日
最后更新
4年前
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Consecutive outpatients (i.e. non-hospitalized patients) with clinically suspected Deep Vein Thrombosis.

排除标准

  • Age less than 18 years.
  • Treated with full-dose anticoagulation for ≥ 24 hours before D-dimer was measured.
  • D-dimer level known before Clinical Pretest Probability documented.
  • Ultrasound of the leg performed before Clinical Pretest Probability was documented
  • Ultrasound was or will be performed in a patient with low Clinical Pretest Probability and a d-dimer \<1000(or equivalent), or with Moderate Clinical Pretest Probability and a D-dimer \<500 (or equivalent) (e.g. suspected bleeding).
  • Ongoing need for anticoagulant therapy.
  • Suspected Pulmonary Embolism.
  • Superficial venous thrombosis that requires, or may require, anticoagulant therapy.
  • Life expectancy less than 3 months.
  • Previously confirmed episode of Deep Vein Thrombosis.

结局指标

主要结局

Confirmed symptomatic proximal Deep Vein Thrombosis

时间窗: within 90 days

The primary outcome is confirmed symptomatic proximal Deep Vein Thrombosis (including involvement of the calf vein trifurcation but not isolated more distal Deep Vein Thrombosis; or pulmonary embolism (not including isolated sub-segmental abnormalities on Computed Tomography Pulmonary Angiogram; within 90 days (± 7 days for follow-up assessment) that is not diagnosed by scheduled diagnostic testing (includes events that occur between initial and scheduled follow-up proximal ultrasound examinations).

次要结局

  • Clinical Pretest Probability/ D-dimer/ Compression Ultrasound subgroups(within 90 days)
  • Death(within 90 days)

研究点 (10)

Loading locations...

相似试验